Digital First Scientific Communications – Defining Omnichannel: An Ongoing Debate
In this podcast, part 1 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How do you define omnichannel?”
In this podcast, part 1 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How do you define omnichannel?”
In the second podcast of this two-part series, we will discuss communicating the value of Field Medical to external stakeholders.
In this first podcast, the first of a two-part series, we will discuss communicating the value of Field Medical to internal stakeholders.
The intent of this webinar is to demonstrate how to conduct gap analyses to identify needs, or deficiencies, within your Medical plan, as well as demonstrate how to apply results of gap analyses to effectively address needs.
In this podcast, two data specialists discuss the ways in which Medical Affairs professionals can use this data to discover your next generation of researchers, those influencers whose voices are heard on Twitter, and how your KOLs are interacting with others online.
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.